National Trends and Outcomes of Acute Myocardial Infarction After Transcatheter Aortic Valve Replacement
JACC: Cardiovascular Interventions · 2024-05 · 17 (10) · 1267-1276
DOI: 10.1016/j.jcin.2024.02.026 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Cardiovascular Interventions, 2024-05. Verfasst von Tanush Gupta und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, University of Vermont Medical Center, Burlington, Vermont, USA. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Non-ST Elevated Myocardial Infarction, Databases, Factual, ST Elevation Myocardial Infarction. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Prior studies have reported decreased use of an invasive approach for acute myocardial infarction (AMI) in patients undergoing transcatheter aortic valve replacement (TAVR). OBJECTIVES: The aim of this study was to determine whether prior TAVR affects the use of subsequent coronary revascularization and outcomes of AMI in a contemporary national data set. METHODS: Consecutive TAVR patients from 2016 to 2022 were identified from the U.S. Vizient Clinical Data Base who were hospitalized after the index TAVR hospitalization with ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI). Patients with STEMI or NSTEMI with or without prior TAVR from the same time period were compared for the use of coronary angiography, revascularization, and in-hospital outcomes. Propensity score matching was used to account for imbalances in patient characteristics. RESULTS: Among 206,229 patients who underwent TAVR, the incidence of STEMI was 25 events per 100,000 person-years of follow-up, and that of NSTEMI was 229 events per 100,000 person-years. After propensity matching, the use of coronary revascularization was similar in the prior TAVR and no TAVR cohorts in both the STEMI (65.3% vs 63.9%; P = 0.81) and NSTEMI (41.4% vs 41.7%; P = 0.88) subgroups. Compared with patients without prior TAVR, in-hospital mortality was higher in the prior TAVR cohort in patients with STEMI (27.1% vs 16.7%; P = 0.03) and lower in those with NSTEMI (5.8% vs 8.2%; P = 0.02). CONCLUSIONS: In this large, national retrospective study, AMI events after TAVR were infrequent. There were no differences in the use of coronary revascularization for STEMI or NSTEMI in TAVR patients compared with the non-TAVR population. In-hospital mortality for STEMI is higher in TAVR patients compared with those without prior TAVR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, University of Vermont Medical Center, Burlington, Vermont, USA.
- Center for Advanced Analytics and Informatics, Vizient, Irving, Texas, USA.
- Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Division of Cardiothoracic Surgery, University of Vermont Medical Center, Burlington, Vermont, USA.
- Division of Cardiology, University of Vermont Medical Center, Burlington, Vermont, USA. Electronic address: harold.dauerman@uvmhealth.org.
Zitieren
APA
Gupta, T., Zimmer, J., Lahoud, R. N., Murphy, H. R., Harris, A. H., Kolte, D., Hirashima, F., & Dauerman, H. L. (2024). National Trends and Outcomes of Acute Myocardial Infarction After Transcatheter Aortic Valve Replacement. JACC: Cardiovascular Interventions, 17(10), 1267-1276. https://doi.org/10.1016/j.jcin.2024.02.026
Vancouver
Gupta T, Zimmer J, Lahoud RN, Murphy HR, Harris AH, Kolte D, et al. National Trends and Outcomes of Acute Myocardial Infarction After Transcatheter Aortic Valve Replacement. JACC: Cardiovascular Interventions. 2024;17(10):1267-1276. doi:10.1016/j.jcin.2024.02.026
BibTeX
@article{Gupta2024,
author = {Gupta, Tanush and Zimmer, Joshua and Lahoud, Rony N and Murphy, Hannah R and Harris, Alyssa H and Kolte, Dhaval and Hirashima, Fuyuki and Dauerman, Harold L},
title = {National Trends and Outcomes of Acute Myocardial Infarction After Transcatheter Aortic Valve Replacement},
journal = {JACC: Cardiovascular Interventions},
year = {2024},
volume = {17},
number = {10},
pages = {1267--1276},
doi = {10.1016/j.jcin.2024.02.026}
}
EUVIMED